DMEMEDS shared post via Reuters: Lilly wins EU backing for copy of Sanofi's top insulin Lantus

LONDON (Reuters) - European regulators have for the first time recommended approval of a copycat insulin for diabetics, posing a threat to French drugmaker Sanofi SASY.PA whose top-selling Lantus is now set to face a cheaper rival in 2015. [Category: healthNews] http://feeds.reuters.com/~r/reuters/healthNews/~3/vTf_mXEIt1k/story01.htm

Read More